Skip to content

Clinical trials

Phase 2 Epilepsy trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Phase: Phase 2 Country / region: France Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20021
20051
20061
20071
20082
20091
20141
20151
20171
20181
20193
20201
20211
20221
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated3
Active, not recruiting1
Enrolling by invitation1
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UCB Pharma4
Eisai Inc.2
GlaxoSmithKline2
Neurocrine Biosciences2
UCB Biopharma S.P.R.L.2
Addex Pharma S.A.1
Assistance Publique - Hôpitaux de Paris1
Bial - Portela C S.A.1
Biohaven Therapeutics Ltd.1
Centre Hospitalier Universitaire de Nice1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy21
Seizures8
Drug Resistant Epilepsy3
Epilepsies, Partial2
Migraine Disorders2
Autistic Disorder1
Focal Cortical Dysplasia1
Migraine with Aura1
Spasm1
Spasms, Infantile1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.